HY-146388-100mg
|
MedChemexpress LLC
|
Mtb ATP synthase-IN-1 [CAS 2642394-38-3]
|
|
COVID-19-immunoregulation
|
|
HY-146388-25mg
|
MedChemexpress LLC
|
Mtb ATP synthase-IN-1 [CAS 2642394-38-3]
|
|
COVID-19-immunoregulation
|
|
HY-146388-5mg
|
MedChemexpress LLC
|
Mtb ATP synthase-IN-1 [CAS 2642394-38-3]
|
|
COVID-19-immunoregulation
|
|
HY-146388-50mg
|
MedChemexpress LLC
|
Mtb ATP synthase-IN-1 [CAS 2642394-38-3]
|
|
COVID-19-immunoregulation
|
|
HY-146388-1mL
|
MedChemexpress LLC
|
Mtb ATP synthase-IN-1 [CAS 2642394-38-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-N1377-10mg
|
MedChemexpress LLC
|
Nevadensin [CAS 10176-66-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-N1377-20mg
|
MedChemexpress LLC
|
Nevadensin [CAS 10176-66-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-N1377-5mg
|
MedChemexpress LLC
|
Nevadensin [CAS 10176-66-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-N8060A-1mg
|
MedChemexpress LLC
|
Orotidine 5?-monophosphate (trisodium) [CAS 68244-58-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-N8060A-5mg
|
MedChemexpress LLC
|
Orotidine 5?-monophosphate (trisodium) [CAS 68244-58-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-N3075-1g
|
MedChemexpress LLC
|
Phytol [CAS 150-86-7]
|
|
COVID-19-immunoregulation
|
|
HY-N3075-1mL
|
MedChemexpress LLC
|
Phytol [CAS 150-86-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-125941-10mg
|
MedChemexpress LLC
|
PNU-101603 [CAS 168828-60-2]
|
|
COVID-19-immunoregulation
|
|
HY-125941-25mg
|
MedChemexpress LLC
|
PNU-101603 [CAS 168828-60-2]
|
|
COVID-19-immunoregulation
|
|
HY-125941-5mg
|
MedChemexpress LLC
|
PNU-101603 [CAS 168828-60-2]
|
|
COVID-19-immunoregulation
|
|
HY-135748A-1mg
|
MedChemexpress LLC
|
Poly (I:C):Kanamycin (1:1) (sodium)
|
|
|
|
HY-135748A-10mg
|
MedChemexpress LLC
|
Poly (I:C):Kanamycin (1:1) (sodium)
|
|
|
|
HY-135748A-25mg
|
MedChemexpress LLC
|
Poly (I:C):Kanamycin (1:1) (sodium)
|
|
|
|
HY-135748A-5mg
|
MedChemexpress LLC
|
Poly (I:C):Kanamycin (1:1) (sodium)
|
|
|
|
HY-10844-10mg
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6]
|
|
COVID-19-immunoregulation
|
|
HY-10844-100mg
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6]
|
|
COVID-19-immunoregulation
|
|
HY-10844-5mg
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6]
|
|
COVID-19-immunoregulation
|
|
HY-10844-50mg
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6]
|
|
COVID-19-immunoregulation
|
|
HY-10844-1mL
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-10844S-1mg
|
MedChemexpress LLC
|
Pretomanid-d4 [CAS 1346617-34-2]
|
|
COVID-19-immunoregulation
|
|